Global Cancer Research and Control Seminar Series 2025 (Upcoming Webinars)
Thursday, February 12, 2026 | 10:00 a.m. to 11:00 a.m. ET
Advancing Cancer Epidemiology Through Global Collaboration (Virtual)
Xiao-Ou Shu, M.D., Ph.D., Associate Director for Global Health & Professor of Medicine
Vanderbilt Ingram Cancer Center & Vanderbilt University Medical Center
Xiao-Ou Shu, M.D., Ph.D., is a chronic disease epidemiologist at Vanderbilt University School of Medicine. She serves as Co-Leader of the Cancer Epidemiology Program and Associate Director for Global Health at the Vanderbilt-Ingram Cancer Center.
An elected Fellow of the American Association for the Advancement of Science (AAAS) and the American College of Epidemiology, Dr. Shu is also a member of the American Epidemiological Society. Since 1996, she has maintained continuous funding from the National Institutes of Health, leading more than 26 major research projects and five training grants. Her research explores how environmental exposures, lifestyle factors, and genetic susceptibility influence disease, particularly cancer risk and outcomes. She also focuses on biomarker discovery through multidisciplinary approaches. Dr. Shu earned her M.D. and M.P.H. from Fudan University Shanghai Medical School and her Ph.D. in epidemiology from Columbia University in New York.
Abstract
Cancer is one of the leading causes of death worldwide, impacting millions across all regions and demographics. Global cancer research is vital to reducing this burden. In this seminar, Dr. Shu will highlight how international collaboration accelerates scientific discovery by leveraging diverse genetic profiles, environmental exposures, and lifestyles. Such cooperation enhances scientific rigor, addresses disparities in cancer incidence and care, and ensures that advances benefit patients everywhere.Thursday, March 12, 2026 | 10:00 a.m. - 11:00 a.m. ET
Technologies for Post Market Surveillance of Drug Quality and an Update on Chemotherapy Drug Quality in sub-Saharan Africa (Virtual)
Marya Lieberman, Ph. D., Nancy Dee Professor of Cancer Research
Department of Chemistry and Biochemistry, University of Notre Dame
Marya Lieberman, Ph.D., is a professor of Chemistry and Biochemistry at the University of Notre Dame. She was the 2025 recipient of the ACS Gustavus John Esselen Award for Chemistry in the Public Interest. Her lab develops paper microfluidic devices and kits for use in field settings, including paper analytical devices used to screen pharmaceutical quality in Africa, carbon fiber filters that can identify lead and copper contamination in tap water, and sample collection kits that help parents locate leaded paint, soil, or dust in their homes. She is currently on the hunt for substandard and fake anticancer drugs in sub-Saharan Africa.